Upstream Bio shares are trading lower after Evercore ISI Group downgraded the stock from Outperform to In-Line and lowered its price target from $40 to $15.

Benzinga Newsdesk www.benzinga.com Negative 97.3%

Neg 97.3% Neu 0% Pos 0%

Comments

No comments yet. Be the first!